Literature DB >> 10921521

Subacute central nervous system degeneration in a child: an unusual manifestation of ifosfamide intoxication.

A Shuper1, J Stein, J Goshen, L Kornreich, I Yaniv, I J Cohen.   

Abstract

A 5-year-old child with desmoplastic small round-cell tumor was treated with a protocol of very-high-dose, short-term chemotherapy, containing HD-CAV (cyclophosphamide, doxorubicin, vincristine, and mesna), ifosfamide, and etoposide. Two days after the initiation of ifosfamide, he exhibited new-onset lethal encephalopathy manifested by subacutely progressive cerebellar and then temporal and frontocortical degeneration leading to a vegetative state and eventually to death. A full work-up, including brain biopsy, was negative, excluding infections and metabolic or vascular causes. Ifosfamide is known to be capable of causing acute encephalopathy that can be severe but is generally reversible. This child showed a very atypical progressive, lethal course of ifosfamide toxicity. The possibility of this complication should be considered when high-dose ifosfamide treatment is planned for children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921521     DOI: 10.1177/088307380001500711

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Isolated subacute combined degeneration in late-onset cobalamin C deficiency in children: Two case reports and literature review.

Authors:  Junling Cui; Yuanyuan Wang; Huifeng Zhang; Xiaopu Cui; Lihui Wang; Huacheng Zheng
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

2.  Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue.

Authors:  Anusha Vakiti; Ravi Pilla; Muhamad Alhaj Moustafa; Jacinth J Joseph; Aarthi G Shenoy
Journal:  J Investig Med High Impact Case Rep       Date:  2018-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.